Baupost Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,467,652
Closed -$65.5M 37
2018
Q4
$65.5M Sell
1,467,652
-3,270,833
-69% -$170M 0.57% 28
2018
Q3
$256M Sell
4,738,485
-361,515
-7% -$18.5M 1.96% 17
2018
Q2
$249M Hold
5,100,000
2.18% 13
2018
Q1
$320M Hold
5,100,000
3.08% 11
2017
Q4
$312M Buy
5,100,000
+2,570,000
+102% +$159M 3.09% 13
2017
Q3
$169M Buy
2,530,000
+500,000
+25% +$35.3M 2.11% 14
2017
Q2
$158M Buy
2,030,000
+1,000,000
+97% +$75.5M 1.81% 16
2017
Q1
$84M Hold
1,030,000
0.99% 20
2016
Q4
$74.1M Buy
+1,030,000
New +$74.5M 0.97% 20

Other funds holding CAH

Baupost Group's CAH Position: Q1 2019 in Review

Baupost Group sold out of Cardinal Health (CAH) in Q1 2019, closing a stake of 1,467,652 shares — an estimated $65.5M sold.

Baupost Group first reported a position in CAH in Q4 2016 and held it in 9 quarters. The position peaked at $320M in Q1 2018. 693 funds tracked by Wall St. Rank hold CAH as of Q1 2019.

  • Baupost Group reported no remaining Cardinal Health position as of Q1 2019 after selling out during the quarter.
  • Baupost Group sold 1,467,652 Cardinal Health shares in Q1 2019, an estimated $65.5M.
  • Baupost Group first reported a position in Cardinal Health in Q4 2016 and held it in 9 quarters.
  • Baupost Group's Cardinal Health position peaked at $320M in Q1 2018.
  • 693 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2019.

Based on Baupost Group's 13F filing for Q1 2019, filed 15 May 2019.